AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wen, Y. L.
Right arrow Articles by Maekawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wen, Y. L.
Right arrow Articles by Maekawa, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Radiofrequency Ablation of Hepatocellular Carcinoma: Therapeutic Response Using Contrast-Enhanced Coded Phase-Inversion Harmonic Sonography

Yan Ling Wen1,2, Masatoshi Kudo1, Rong Qin Zheng1,3, Yasunori Minami1, Hobyung Chung1, Yoichiro Suetomi1, Hirokazu Onda1, Masayuki Kitano1, Toshihiko Kawasaki1 and Kiyoshi Maekawa4

1 Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
2 Present address: Department of Ultrasound, The Second Affiliated Hospital, Sun Yat-sen University, 107 Yanjiangxi Rd., Guangzhou 510-120, China.
3 Present address: Department of Ultrasound, The Third Affiliated Hospital, Sun Yat-sen University, Shipai, Guangzhou 510-630, China.
4 Abdominal Ultrasound Unit, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.



View larger version (21K):

[in a new window]
 
Fig. 1. Diagram illustrates safety margin of ablated peritumoral liver tissue that is located between necrotic tumor and unablated liver tissue. Safety margin appears as hypoattenuating area on three-phase dynamic CT and as hypovascular area on contrast-enhanced imaging with coded harmonic angio software (General Electric Medical Systems, Milwaukee, WI), similar to ablated tumor.

 


View larger version (157K):

[in a new window]
 
Fig. 2A. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. Before treatment, subcostal scanning, which was used with contrast-enhanced coded harmonic angio software (General Electric Medical Systems, Milwaukee, WI), shows strong gray-scale blood signals (arrows) within entire tumor on interval-delay scanning.

 


View larger version (116K):

[in a new window]
 
Fig. 2B. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. Arterial phase dynamic CT scan obtained before radiofrequency ablation shows hepatocellular carcinoma (arrow) as homogenous high-attenuated tumor.

 


View larger version (137K):

[in a new window]
 
Fig. 2C. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. One week after first session of radiofrequency ablation, contrast-enhanced coded harmonic angio reveals strongly enhanced tumor parenchymal stain (arrowheads) after administration of contrast agent Levovist (Schering, Berlin, Germany) in area of tumor that suggested incomplete response to radiofrequency ablation.

 


View larger version (141K):

[in a new window]
 
Fig. 2D. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. Arterial phase of dynamic CT scan obtained same day as coded harmonic angio (C) confirms residual tumor by high attenuation in portion of tumor (arrowheads).

 


View larger version (129K):

[in a new window]
 
Fig. 2E. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. On contrast-enhanced sonogram obtained with coded harmonic angio 1 week after second session of radiofrequency ablation, perfusion defect area of tumor is shown that suggests complete effect of radiofrequency ablation.

 


View larger version (135K):

[in a new window]
 
Fig. 2F. 77-year-old woman with 1.5-cm hepatocellular carcinoma nodule in segment VIII. On arterial phase dynamic CT scan acquired same day as E, lack of enhancement in area of tumor is shown and confirms treatment response to be complete.

 


View larger version (133K):

[in a new window]
 
Fig. 3A. 56-year-old man with 1.0-cm hepatocellular carcinoma in segment VI. Before radiofrequency ablation, contrast-enhanced sonogram obtained with coded harmonic angio software (General Electric Medical Systems, Milwaukee, WI) shows few tumor vessels within hepatocellular carcinoma (arrows) in early arterial phase.

 


View larger version (148K):

[in a new window]
 
Fig. 3B. 56-year-old man with 1.0-cm hepatocellular carcinoma in segment VI. Tumor was shown to be high attenuating on arterial phase dynamic CT scan (arrowhead).

 


View larger version (168K):

[in a new window]
 
Fig. 3C. 56-year-old man with 1.0-cm hepatocellular carcinoma in segment VI. After two sessions of radiofrequency ablation, coded harmonic angio of tumor parenchymal stain shows larger perfusion defect area (arrows) than ablated tumor (circle), which suggests large enough safety margin.

 


View larger version (153K):

[in a new window]
 
Fig. 3D. 56-year-old man with 1.0-cm hepatocellular carcinoma in segment VI. On arterial phase dynamic CT scan, low-attenuation area apparently larger (5 mm) than ablated tumor (arrow) was identified, and complete response with enough safety margin was confirmed.

 


View larger version (12K):

[in a new window]
 
Fig. 4A. Flow charts show therapeutic strategy of radiofrequency ablation. Before introduction of contrast-enhanced imaging with coded harmonic angio software (General Electric Medical Systems, Milwaukee, WI), dynamic CT must be performed after each session of radiofrequency ablation to assess therapeutic response.

 


View larger version (19K):

[in a new window]
 
Fig. 4B. Flow charts show therapeutic strategy of radiofrequency ablation. After introduction of contrast-enhanced imaging with coded harmonic angio, residual tumor can be clearly identified on sonographic imaging plane that can be used as effective guidance for further radiofrequency ablation. Dynamic CT was performed only for assessing safety margin when treatment was evaluated to be complete on contrast-enhanced coded harmonic angio.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.